The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease

R Sharma, M Guy, A Rudenski… - QJM: an international …, 2009 - academic.oup.com
The absorption of digoxin from the intestine is between 70% and 90% depending on the
type of preparation used eg elixir, capsule, etc. 2 Digoxin has a large volume of distribution …
被引用次数：2 相关文章

[引用][C] The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease.

R Sharma, M Guy, A Rudenski, E Lamerton… - QJM: Monthly Journal …, 2009 - europepmc.org
The limitations of routine total digoxin immunoassay in patients with advanced chronic
kidney disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[引用][C] The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease

R Sharma, M Guy, A Rudenski… - QJM: an …, 2009 - research.manchester.ac.uk
The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney
disease — Research Explorer The University of Manchester Skip to main navigation Skip to …

[引用][C] The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease

R Sharma, M Guy, A Rudenski… - … : monthly journal of …, 2009 - pubmed.ncbi.nlm.nih.gov

The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease.

R Sharma, M Guy, A Rudenski… - … Journal of Medicine, 2009 - search.ebscohost.com
The article discusses two clinical scenarios involving digoxin levels in older patients with
advanced chronic kidney disease (CKD). Several patients with CKD are prescribed with …

[引用][C] The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease

R SHARMA, M GUY, A RUDENSKI, E LAMERTON… - QJM, 2009 - Oxford University Press